Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers
- 15 June 2009
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 179 (12), 1107-1114
- https://doi.org/10.1164/rccm.200810-1584oc
Abstract
Rationale: Simvastatin inhibits inflammatory responses in vitro and in murine models of lung inflammation in vivo. As simvastatin modulates a number of the underlying processes described in acute lung injury (ALI), it may be a potential therapeutic option. Objectives: To investigate in vivo if simvastatin modulates mechanisms important in the development of ALI in a model of acute lung inflammation induced by inhalation of lipopolysaccharide (LPS) in healthy human volunteers. Methods: Thirty healthy subjects were enrolled in a double-blind, placebo-controlled study. Subjects were randomized to receive 40 mg or 80 mg of simvastatin or placebo (n = 10/group) for 4 days before inhalation of 50 μg LPS. Measurements were performed in bronchoalveolar lavage fluid (BALF) obtained at 6 hours and plasma obtained at 24 hours after LPS challenge. Nuclear translocation of nuclear factor-κB (NF-κB) was measured in monocyte-derived macrophages. Measurements and Main Results: Pretreatment with simvastatin reduced LPS-induced BALF neutrophilia, myeloperoxidase, tumor necrosis factor-α, matrix metalloproteinases 7, 8, and 9, and C-reactive protein (CRP) as well as plasma CRP (all P < 0.05 vs. placebo). There was no significant difference between simvastatin 40 mg and 80 mg. BALF from subjects post-LPS inhalation induced a threefold up-regulation in nuclear NF-κB in monocyte-derived macrophages (P < 0.001); pretreatment with simvastatin reduced this by 35% (P < 0.001). Conclusions: Simvastatin has antiinflammatory effects in the pulmonary and systemic compartment in humans exposed to inhaled LPS. Clinical trial registered with www.controlled-trials.com (ISRCTN21056528).This publication has 50 references indexed in Scilit:
- The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophagesClinical and Experimental Immunology, 2008
- Prolonged survival of neutrophils from patients with F508 CFTR mutationsThorax, 2008
- In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injuryThorax, 2007
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Pretreatment with Simvastatin Reduces Lung Injury Related to Intestinal Ischemia-Reperfusion in RatsAnesthesia & Analgesia, 2006
- Time Course of Rapid C-Reactive Protein Reduction by Pravastatin in Patients with Stable AnginaAngiology, 2006
- Simvastatin Blunts Endotoxin-Induced Tissue Factor In VivoCirculation, 2005
- Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteersThrombosis and Haemostasis, 2005
- Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemiaInternational Journal of Cardiology, 2004
- The Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000